Our ETF Speculation Index gave a new buy signal last week and other asset flow data points to aggregate pessimism in the ETF investing crowd. Additionally, Biotech ETFs are showing relative strength and technical breakouts. We're recommending a trade on XBI in the ETF Strategy.
Complete the form and a member of our team will send you a copy of this publication.
While you wait, explore additional NDR research and solutions.
Institutional Investors
Custom Research
Wealth Managers
Stock Selection
ETF Selection
Please note that you are using an unsupported browser. While the site will continue to function, you might experience sub-optimal behavior until you upgrade. Please update your browser to a later version for a better experience.